| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Loly JP et al. | Guillain-Barré syndrome following hepatitis E. | 2009 | World J. Gastroenterol. | pmid:19340910 |
| Yamato O et al. | GM2-gangliosidosis variant 0 (Sandhoff-like disease) in a family of Japanese domestic cats. | 2004 | Vet. Rec. | pmid:15623087 |
| Kosanke SD et al. | Clinical and biochemical abnormalities in porcine GM2-gangliosidosis. | 1978 | Vet. Pathol. | pmid:108843 |
| Singer HS and Cork LC | Canine GM2 gangliosidosis: morphological and biochemical analysis. | 1989 | Vet. Pathol. | pmid:2540585 |
| Heffer-Lauc M et al. | Glycoprotein and ganglioside changes in human trophoblasts after exposure to pulsed Doppler ultrasound. | 1995 | Ultrasound Med Biol | pmid:7571151 |
| Mattson MP | New blood cells help an overburdened brain. | 2001 | Trends Neurosci. | pmid:11163874 |
| Eto Y et al. | Partial deficiency of beta-hexosaminidase activity in canine GM2-gangliosidosis. | 1987 | Tohoku J. Exp. Med. | pmid:2958961 |
| Rupp A et al. | The effects of age and ganglioside composition on the rate of motor nerve terminal regeneration following antibody-mediated injury in mice. | 2013 | Synapse | pmid:23401234 |
| Cork LC et al. | GM2 ganglioside lysosomal storage disease in cats with beta-hexosaminidase deficiency. | 1977 | Science | pmid:404709 |
| Platt FM et al. | Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin. | 1997 | Science | pmid:9103204 |
| Vite CH et al. | Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease. | 2015 | Sci Transl Med | pmid:25717099 |
| Yoshimura A et al. | GD2 ganglioside-specific monoclonal antibody reacts with murine cytotoxic T lymphocytes reactive with FBL-3N erythroleukaemia. | 1994 | Scand. J. Immunol. | pmid:7973461 |
| Arai M and Kusunoki S | [A case of multifocal motor neuropathy with IgM lambda anti-GM1 antibody and IgM kappa paraprotein reacting exclusively with GM2]. | Rinsho Shinkeigaku | pmid:19348179 | |
| Klisch K et al. | The Sda/GM2-glycan is a carbohydrate marker of porcine primordial germ cells and of a subpopulation of spermatogonia in cattle, pigs, horses and llama. | 2011 | Reproduction | pmid:21896636 |
| Chen S et al. | Quantitative analysis of the molecular species of monosialogangliosides by continuous-flow fast-atom bombardment mass spectrometry. | 1991 | Rapid Commun. Mass Spectrom. | pmid:1811797 |
| Schütte CG et al. | Complete localization of disulfide bonds in GM2 activator protein. | 1998 | Protein Sci. | pmid:9568910 |
| Tai T et al. | Ganglioside GM2 as a human tumor antigen (OFA-I-1). | 1983 | Proc. Natl. Acad. Sci. U.S.A. | pmid:6193515 |
| Conzelmann E and Sandhoff K | AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2. | 1978 | Proc. Natl. Acad. Sci. U.S.A. | pmid:99746 |
| Holmgren J et al. | Interaction of cholera toxin and membrane GM1 ganglioside of small intestine. | 1975 | Proc. Natl. Acad. Sci. U.S.A. | pmid:1058471 |
| Takamiya K et al. | Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. | 1996 | Proc. Natl. Acad. Sci. U.S.A. | pmid:8855236 |
| Kitamura K et al. | Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine. | 1995 | Proc. Natl. Acad. Sci. U.S.A. | pmid:7708728 |
| Dobrenis K et al. | Neuronal lysosomal enzyme replacement using fragment C of tetanus toxin. | 1992 | Proc. Natl. Acad. Sci. U.S.A. | pmid:1532255 |
| Goodman LA et al. | Ectopic dendrites occur only on cortical pyramidal cells containing elevated GM2 ganglioside in alpha-mannosidosis. | 1991 | Proc. Natl. Acad. Sci. U.S.A. | pmid:1763046 |
| Guan F et al. | Specific glycosphingolipids mediate epithelial-to-mesenchymal transition of human and mouse epithelial cell lines. | 2009 | Proc. Natl. Acad. Sci. U.S.A. | pmid:19380734 |
| Yamaguchi H et al. | Human monoclonal antibody with dual GM2/GD2 specificity derived from an immunized melanoma patient. | 1990 | Proc. Natl. Acad. Sci. U.S.A. | pmid:2159145 |
| Todeschini AR et al. | Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway. | 2008 | Proc. Natl. Acad. Sci. U.S.A. | pmid:18272501 |
| Paw BH et al. | Molecular basis of adult-onset and chronic GM2 gangliosidoses in patients of Ashkenazi Jewish origin: substitution of serine for glycine at position 269 of the alpha-subunit of beta-hexosaminidase. | 1989 | Proc. Natl. Acad. Sci. U.S.A. | pmid:2522660 |
| Livingston PO et al. | Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients. | 1987 | Proc. Natl. Acad. Sci. U.S.A. | pmid:3472242 |
| Lemos M et al. | Prenatal diagnosis of GM2-gangliosidosis B1 variant. | 1995 | Prenat. Diagn. | pmid:7659693 |
| Worstell NC et al. | Binding Cooperativity Matters: A GM1-Like Ganglioside-Cholera Toxin B Subunit Binding Study Using a Nanocube-Based Lipid Bilayer Array. | 2016 | PLoS ONE | pmid:27070150 |
| Caughlin S et al. | Increased Expression of Simple Ganglioside Species GM2 and GM3 Detected by MALDI Imaging Mass Spectrometry in a Combined Rat Model of Aβ Toxicity and Stroke. | 2015 | PLoS ONE | pmid:26086081 |
| Mahata B et al. | GBM Derived Gangliosides Induce T Cell Apoptosis through Activation of the Caspase Cascade Involving Both the Extrinsic and the Intrinsic Pathway. | 2015 | PLoS ONE | pmid:26226135 |
| Sinici I et al. | In cellulo examination of a beta-alpha hybrid construct of beta-hexosaminidase A subunits, reported to interact with the GM2 activator protein and hydrolyze GM2 ganglioside. | 2013 | PLoS ONE | pmid:23483939 |
| Wilkinson FL et al. | Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB. | 2012 | PLoS ONE | pmid:22558223 |
| Kodama T et al. | Lyso-GM2 ganglioside: a possible biomarker of Tay-Sachs disease and Sandhoff disease. | 2011 | PLoS ONE | pmid:22205997 |
| Sargeant TJ et al. | Characterization of inducible models of Tay-Sachs and related disease. | 2012 | PLoS Genet. | pmid:23028353 |
| Seyrantepe V et al. | Mice doubly-deficient in lysosomal hexosaminidase A and neuraminidase 4 show epileptic crises and rapid neuronal loss. | 2010 | PLoS Genet. | pmid:20862357 |
| Mikami M et al. | Characteristic alteration in the concentration of IV 3NeuAc alpha-nLc4Cer in the villi of human placenta during the gestational period. | Placenta | pmid:8248034 | |
| Pullarkat RK et al. | Accumulation of ganglioside Gm2 in cerebrospinal fluid of a patient with the variant AB of infantile Gm2 gangliosidosis. | 1981 | Pediatrics | pmid:7243492 |
| Strømme P et al. | Encephaloneuropathy with lysosomal zebra bodies and GM2 ganglioside storage. | 1997 | Pediatr. Neurol. | pmid:9090689 |
| Ishigaki H et al. | Childhood-Onset Multifocal Motor Neuropathy With Immunoglobulin M Antibodies to Gangliosides GM1 and GM2: AÂ Case Report and Review of the Literature. | 2016 | Pediatr. Neurol. | pmid:27400822 |
| Smyth KA et al. | Acquired infantile abducens palsy associated with anti-GM2 antibodies. | 2011 | Pediatr. Neurol. | pmid:21555058 |
| Rapola J | Lysosomal storage diseases in adults. | 1994 | Pathol. Res. Pract. | pmid:7831151 |
| Whitehead B et al. | Experiences of dying, death and bereavement in motor neurone disease: a qualitative study. | 2012 | Palliat Med | pmid:21712334 |
| Jacques S et al. | Chemoenzymatic synthesis of GM3 and GM2 gangliosides containing a truncated ceramide functionalized for glycoconjugate synthesis and solid phase applications. | 2006 | Org. Biomol. Chem. | pmid:16358009 |
| Andersen SM et al. | Synthesis of ganglioside epitopes for oligosaccharide specific immunoadsorption therapy of Guillian-Barré syndrome. | 2004 | Org. Biomol. Chem. | pmid:15064799 |
| Sango K et al. | Involvement of retinal neurons and pigment epithelial cells in a murine model of sandhoff disease. | 2008 | Ophthalmic Res. | pmid:18437034 |
| Tada M et al. | [Steroid-pulse therapy in Guillain-Barré syndrome associated with cytomegalovirus infection: a case report]. | 2003 | No To Shinkei | pmid:12910997 |
| Walkley SU | Pyramidal neurons with ectopic dendrites in storage diseases exhibit increased GM2 ganglioside immunoreactivity. | 1995 | Neuroscience | pmid:8544979 |
| Mizutani K et al. | Enhancement of TNF-alpha production by ganglioside GM2 in human mononuclear cell culture. | 1999 | Neuroreport | pmid:10208534 |
Ganglioside GM2
Ganglioside GM2 is a lipid of Sphingolipids (SP) class. Ganglioside gm2 is associated with abnormalities such as Sensory neuropathy, Neuropathy, Autoimmune Diseases, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating and Neuromuscular Diseases. The involved functions are known as Pressure- physical agent, Cytolysis, Inflammation, Complement-Dependent Cytotoxicity and conjugation. Ganglioside gm2 often locates in Membrane, Entire nervous system, Cell surface, Biopsy sample and Lipid Bilayers. The associated genes with Ganglioside GM2 are anti-IgM, Polypeptides, Transgenes, Alleles and Homologous Gene. The related lipids are Ganglioside GA2, QS 21, sulfate-3-glucuronyl paragloboside, Lipopolysaccharides and IV(4)-galactosyl-N-acetylganglioside GD1a. The related experimental models are Disease model.
Cross Reference
Introduction
To understand associated biological information of Ganglioside GM2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Ganglioside GM2?
Ganglioside GM2 is suspected in Tay-Sachs Disease, Gangliosidoses GM2, Sandhoff Disease, Neuropathy, Cytomegalovirus Infections, Niemann-Pick Diseases and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with Ganglioside GM2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Ganglioside GM2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Ganglioside GM2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Ganglioside GM2?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Ganglioside GM2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Ganglioside GM2?
Disease model
Disease model are used in the study 'Development of GlcNAc-inspired iminocyclitiols as potent and selective N-acetyl-beta-hexosaminidase inhibitors.' (Ho CW et al., 2010) and Disease model are used in the study 'Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.' (Tsuji D et al., 2007).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.